+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Severe fatigue and reduced quality of life in children with hereditary motor and sensory neuropathy 1A



Severe fatigue and reduced quality of life in children with hereditary motor and sensory neuropathy 1A



Journal of Child Neurology 28(4): 429-434



Severe fatigue and low quality of life are reported by a majority of adult patients with hereditary motor and sensory neuropathy 1A. In children with hereditary motor and sensory neuropathy 1A, the prevalence and impact of fatigue have not been studied yet. In this questionnaire survey, 55 Dutch children (response rate 77%) with genetically confirmed hereditary motor and sensory neuropathy 1A participated (mean age 15 years [standard deviation 2.1]). Prevalence of severe fatigue (based on a cut-off score of the Checklist Individual Strength) was 24%, in contrast to 14% in a Dutch school-based population (P < .05). Almost all quality-of-life scores (measured with the Child Health Questionnaire-Child Form 87) were significantly worse than population norms (P < .05). Fatigue severity was associated significantly (P < .01) with all quality-of-life scores (-0.4 < r < -0.7). In conclusion, severe fatigue and diminished quality of life are more frequent among children with hereditary motor and sensory neuropathy 1A compared to healthy peers. The strong association between fatigue severity and quality of life suggests a negative impact of fatigue on quality of life in these children.

(PDF emailed within 0-6 h: $19.90)

Accession: 036725385

Download citation: RISBibTeXText

PMID: 22752492

DOI: 10.1177/0883073812447681


Related references

Ulcero-mutilating neuropathy in an Austrian kinship without linkage to hereditary motor and sensory neuropathy IIB and hereditary sensory neuropathy I loci. Neurology 54(1): 45-52, Jan 11, 2000

Hand strength and fatigue in patients with hereditary motor and sensory neuropathy (types I and II). Archives of Physical Medicine and Rehabilitation 83(9): 1274-1278, 2002

Jumping Mechanography as a Complementary Testing Tool for Motor Function in Children with Hereditary Motor and Sensory Neuropathy. Neuropediatrics 48(6): 420-425, 2017

Foot deformities in children with hereditary motor and sensory neuropathy. Journal of Pediatric Orthopedics 25(2): 241-244, 2005

Hereditary motor and sensory neuropathy hmsn types i and iii in children. Neurology 40(4 SUPPL 1): 345, 1990

Lipid abnormalities in hereditary neuropathy part 3 plasma and erythrocyte lipids of hereditary motor and sensory neuropathy type iii dejerine sottas disease. Journal of the Neurological Sciences 38(1): 59-66, 1978

Clinical practice of hereditary motor neuropathy (HMN) and hereditary sensory and autonomic neuropathy (HSAN). Rinsho Shinkeigaku 54(12): 957-959, 2015

Hereditary motor and sensory neuropathy in children clinical and electrophysiological studies. Journal of Neurology 232(SUPPL): 207, 1985

Children with reduced sensitivity to pain: assessment of hereditary sensory neuropathy types II and IV. Developmental Medicine and Child Neurology 24(6): 785-797, 1982

Hereditary sensory and motor neuropathy and hereditary sensory and autonomic neuropathies: recent advances. Revue Neurologique 167(12): 948-950, 2012

Loss of sensitivity, daily life activity and functional impairments in Hereditary Motor-Sensory Neuropathy. Foot and Ankle Surgery 22(2): 105-106, 2016

Recognizing signs of asymptomatic hereditary motor-sensory neuropathy can prevent severe neurotoxicity of polychemotherapy by avoiding vincristine. Onkologie 23(Sonderheft 7): 187, 2000

Hereditary motor and sensory neuropathy type II followed in the next two generations by a clinically distal motor neuropathy. Clinical and Experimental Neurology 26: 65-72, 1989

Central motor conduction in hereditary motor and sensory neuropathy and hereditary spastic paraplegia. Electromyography and Clinical Neurophysiology 39(6): 331-335, 1999

Early recognition of hereditary motor and sensory neuropathy type 1 can avoid life-threatening vincristine neurotoxicity. British Journal of Haematology 115(2): 323-325, 2001